22nd Century is a New York-based biotech firm that manufactures and supplies products such as VLNC tobacco cigarettes and smoking cessation for the pharmaceutical sector.
Business Model:
Revenue: $50.9M
Employees: 51-200
Address: 500 Seneca Street
City: Buffalo
State: NY
Zip: 14204
Country: US
22nd Century is a New York-based biotech firm that manufactures and supplies products such as VLNC tobacco cigarettes and smoking cessation for the pharmaceutical sector.
Contact Phone:
+17162701523
Contact Email:
Listed Exchange:
NYSE
IPO Date:
2/4/2011
Ticker Symbol:
XXII
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2022 | Post-IPO Equity | $35M | 3/2021 | Post-IPO Debt | $3.7M | 11/2012 | Post-IPO Equity | $2.4M | 5/2022 | Post-IPO Equity | $58M | 10/2016 | Post-IPO Equity | $11.4M | 10/2017 | Post-IPO Equity | $54M | 6/2021 | Post-IPO Equity | $40M | 12/2011 | Post-IPO Debt | $1.9M | 12/2010 | Venture Round | $100k | 9/2014 | Post-IPO Equity | 1 | $10M |
Crede CG III LTD Crede CG III LTD |
9/2014 | Post-IPO Debt | $50k | 8/2012 | Post-IPO Debt | $530k |
---|
Announced Date | Name | Price |
---|---|---|
5/2022 | GVB Biopharma |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|